To Receive Your CME/CPD Certificate
The CME/CPD certificate will be available after completing the online evaluation and credit claiming procedure. The process takes about 5 minutes. We thank you for your feedback as it is an important part of CME/CPD accreditation and helps improve future educational offerings.
Before June 14, 2021:
1. Access the online system
- Visit the following link: https://www.surveymonkey.com/r/ADPD2021Evaluation
Kindly note that the ADPD 2021 online evaluation will be active on the last day of the meeting. You will then be able to access it and claim your CME/CPD certificate.
- Please note that web browsers Mozilla Firefox 2.X or higher, or Google Chrome are recommended
- Visit the CME/CPD Accreditation page on the event website
2. Complete the anonymous online evaluation
3. Complete the credit claim form and submit
4. The CME/CPD certificate will be available for download; retain for your personal records
Commitment to the Highest Standards in CME/CPD
Kenes is committed to being a valuable and knowledgeable partner in the design and delivery of educationally strong, independent, transparent, and effective CME/CPD programmes. Kenes is a proud member of the Good CME Practice Group (gCMEp), a member organisation contributing to improving health outcomes by:
- Championing best practice in CME/CPD
- Maintaining and improving standards
- Mentoring and educating
- Working in collaboration with critical stakeholders
Membership in the Good CME Practice Group illustrates the Kenes commitment to high standards and knowledgeable partnership with its clients in the design and delivery of educationally strong, independent, transparent, effective, and financially viable medical events.
Accreditation Statement and Credit Designation
European Accreditation Council for Continuing Medical Education (UEMS/EACCME)
The 15th International Conference on Alzheimer’s and Parkinson’s Diseases is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS): www.uems.net.
The 15th International Conference on Alzheimer’s and Parkinson’s Diseases is designated for a maximum of, or up to, 47 European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
American Medical Association (AMA)
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/cme/uemseaccme-cme-credit-recognition.
Royal College of Physicians and Surgeons of Canada
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. For more information, visit www.royalcollege.ca/rcsite/cpd/providers/international-accreditation-agreements-e.
Each participant should claim only those hours of credit that he/she actually spent in the educational activity.
After attending this event, participants should be able to:
- Address individual needs in compliance with their Continuous Professional Development (CPD) plan
- Enhance dialogue with clinical investigators and basic scientists, as well as established investigators and young upcoming talents
- Assess the impact of COVID-19 on neurodegenerative diseases
- Evaluate the most recent research in treatment development and emerging therapeutic targets in Alzheimer’s disease
- Describe current developments in the treatment of Parkinson’s disease and related neurological disorders
- Evaluate the novel approaches to disease-modifying therapies of Parkinson’s disease
- Discuss common features of neurodegenerative diseases
- Evaluate the most recent advances about drug development and clinical trials in Huntington’s and other neurodegenerative diseases
The International Conference on Alzheimer’s and Parkinson’s Diseases is the global meeting place for international medical and scientific professionals worldwide engaged in the neurodegeneration field, from basic scientists to clinical investigators, and from established leaders to young upcoming talents. Because of the diverse, clinically focused educational offering, participants are able to tailor the curriculum to meet the needs of international clinicians of all levels of experience.
Disclosure and Resolution of Personal Conflicts of Interest
In accordance with CME/CPD accreditation criteria and standards for commercial support to ensure balance, independence, objectivity, and scientific rigor, those in control of the educational content must disclose potential or actual conflicts of interest. Disclosure information is evaluated and conflicts of interest resolved. Disclosure is made to participants prior to the activity. Participants will be asked on the evaluation to assess the objectivity and independence of the event.
- View Disclosure information here.
Industry Support Disclosure
This event is supported, in part, by funding from industry. All support is managed in strict accordance with CME/CPD accreditation criteria and standards for commercial support. Appropriate acknowledgement of all supporting organisations is made in the programme guide, on the event website, and with signage during the event.